Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Ascribe Bio Raises $12M Series A Led by Corteva Catalyst and Acre Venture Partners
Series AVenture Capital

Ascribe Bio Raises $12M Series A Led by Corteva Catalyst and Acre Venture Partners

•October 15, 2025
•Oct 15, 2025
0

Participants

ascribe

ascribe

company

Corteva

Corteva

investor

Acre Venture Partners

Acre Venture Partners

investor

Syngenta Group Ventures

Syngenta Group Ventures

investor

Trailhead Capital

Trailhead Capital

investor

Silver Blue

Silver Blue

investor

Cultivation Capital

Cultivation Capital

investor

The Yield Lab

The Yield Lab

investor

Deal Summary

Ascribe Bio closed a $12M Series A round co-led by Corteva (via Corteva Catalyst) and Acre Venture Partners, with participation from Syngenta Group Ventures, Trailhead Capital, Silver Blue LLC, Cultivation Capital, and The Yield Lab. The Ithaca-based natural crop protection company will use the funds to advance its products and growth.

0

Comments

Want to join the conversation?

Loading comments...